Regenerative cellular therapies for neurologic diseases

• Stem cell therapies are currently being tested in a number of neurological diseases.
• No stem cell therapy has yet been approved, but the science is progressing.
• This review summarizes the current state of the field of regenerative neurology.

The promise of stem cell regeneration has been the hope of many neurologic patients with permanent damage to the central nervous system. There are hundreds of stem cell trials worldwide intending to test the regenerative capacity of stem cells in various neurological conditions from Parkinson׳s disease to multiple sclerosis. Although no stem cell therapy is clinically approved for use in any human disease indication, patients are seeking out trials and asking clinicians for guidance. This review summarizes the current state of regenerative stem cell transplantation divided into seven conditions for which trials are currently active: demyelinating diseases/spinal cord injury, amyotrophic lateral sclerosis, stroke, Parkinson׳s disease, Huntington׳s disease, macular degeneration and peripheral nerve diseases.This article is part of a Special Issue entitled SI: PSC and the brain.